However, at a dose of 1.5 mg/kg, no significant changes in serum ALT and AST were observed in H22 tumor-bearing mice after treatment with AAGL (Supplementary Figure S3C); therefore, AAGL exhibits few liver toxicological effects on tumor-bearing mice at a dose of 1.5 mg/kg. The gene discussed is GPT; the disease is neoplasm.